| Literature DB >> 8387260 |
Y Inouye1, Y Tokutake, T Yoshida, Y Seto, H Hujita, K Dan, A Yamamoto, S Nishiya, T Yamase, S Nakamura.
Abstract
A screening for inhibitors of human immunodeficiency virus type 1 (HIV-1) among various types of isopolyoxomolybdates and heteropolyoxomolybdates was carried out by using an in vitro assay system measuring the cytopathogenicity of HIV-1 in CD4+ human MT-4 cells. A novel heteropolyoxomolybdate named PM-104 with the chemical formula (NH4)12H2(Eu4(MoO4)(H2O)16(Mo7O24)4).13H2O was found to be associated with potent anti-HIV-1 activity. PM-104 interferes with virus infection at a very early step such as adsorption and/or penetration into the cells. In addition to the cytopathic effect of HIV-1 on MT-4 cells, syncytium formation between mock-infected MOLT-4 cells and MOLT-4 cells chronically infected with either HIV-1 or HIV-2 is suppressed by PM-104. PM-104 also blocks the replication of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). The antiviral properties of PM-104 could be attributed to the combined effect of europium atoms and its peculiar three-dimensional anion structure.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8387260 DOI: 10.1016/0166-3542(93)90075-t
Source DB: PubMed Journal: Antiviral Res ISSN: 0166-3542 Impact factor: 5.970